Description
| Item ID # | 12868900 |
| Manufacturer # | 1286368 |
| Brand | |
Features
- Preservative free
- Sulfite free
- 30 individually wrapped and bar coded vials
Beta-Adrenergic Agonist Albuterol Sulfate, Preservative Free 0.042%, 1.25 mg / 3 mL Unit Dose, Inhalation Solution Nebulizer Vial 30 Vials
UOM CARTON/30
$49.84
Features
- Preservative free
- Sulfite free
- 30 individually wrapped and bar coded vials
10000 in stock
Related products
-
#58908900 Mfr#Menactra® Meningitis Vaccine Meningococcal (Groups A,C,Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine, Preservative Free 4 mcg / 0.5 mL Injection Single Dose Vial 0.5 mL
Features
- Menactra is indicated for active immunization of individuals 2 through 55 years of age for the prevention of invasive meningococcal disease
- Menactra vaccine is administered as a 0.5 mL dose by intramuscular injection
- In children 9 through 23 months of age, Menactra is given as a 2-dose series three months apart
-
#30498901 Mfr# 00003029328Kenalog®-40 Corticosteroid Triamcinolone Acetonide 40 mg / mL Intramuscular or Intra-articular Injection Vial 10 mL
Features
- This drug should not be used in neonates
- Not for intravenous, intradermal, intraocular, epidural, or intrathecal use
- Kenalog®-40 Injection (triamcinolone acetonide injectable suspension, USP) is a synthetic glucocorticoid corticosteroid with anti-inflammatory action
-
#12548900 Mfr# 1254804Antimuscarinic / Antispasmodic Ipratropium Bromide 0.02%, 0.2 mg / mL Unit Dose, Inhalation Solution Vial 25 Vials
Item ID # 12548900 Manufacturer # 1254804 Brand -
#58908900 Mfr# 589-05
Menactra® Meningitis Vaccine Meningococcal (Groups A,C,Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine, Preservative Free 4 mcg / 0.5 mL Injection Single Dose Vial 0.5 mL
Features
- Menactra is indicated for active immunization of individuals 2 through 55 years of age for the prevention of invasive meningococcal disease
- Menactra vaccine is administered as a 0.5 mL dose by intramuscular injection
- In children 9 through 23 months of age, Menactra is given as a 2-dose series three months apart